Clinical Heterogeneity And Diagnostic Delay Of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Syndrome
Date
2011Author
Mazza, Cinzia
Buzi, Fabio
Ortolani, Federica
Vitali, Alberto
Notarangelo, Lucia D.
Weber, Giovanna
Bacchetta, Rosa
Soresina, Annarosa
Lougaris, Vassilios
Greggio, Nella A.
Taddio, Andrea
Pasic, Srdjan
de Vroede, Monique
Pac, Malgorzata
Kilic, Sara Sebnem
Ozden, Sanal
Rusconi, Roberto
Martino, Silvana
Capalbo, Donatella
Salerno, Mariacarolina
Pignata, Claudio
Radetti, Giorgio
Maggiore, Giuseppe
Plebani, Alessandro
Notarangelo, Luigi D.
Badolato, Raffaele
xmlui.mirage2.itemSummaryView.MetaData
Show full item recordAbstract
Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare autosomal recessive organ-specific autoimmune disorder that is characterized by a variable combination of (i) chronic mucocutaneous candidiasis, (ii) polyendocrinopathy and/or hepatitis and (iii) dystrophy of the dental enamel and nails. We analyzed the AIRE (autoimmune regulator) gene in subjects who presented any symptom that has been associated with APECED, including candidiasis and autoimmune endocrinopathy. We observed that 83.3% of patients presented at least two of the three typical manifestations of APECED, while the remaining 16.7% of patients showed other signs of the disease. Analysis of the genetic diagnosis of these subjects revealed that a considerable delay occurs in the majority of patients between the appearance of symptoms and the diagnosis. Overall, the mean diagnostic delay in our patients was 10.2 years. These results suggest that molecular analysis of AIRE should be performed in patients with relapsing mucocutaneous candidiasis for early identification of APECED. (C) 2011 Elsevier Inc. All rights reserved.